Fertility and Sterility
Volume 94, Issue 1 , Pages 130-137 , June 2010

Variations in folate pathway genes are associated with unexplained female infertility

  • Signe Altmäe, M.Sc.

      Affiliations

    • Department of Clinical Science, Intervention and Technology, Division of Obstetrics and Gynecology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
    • Department of Biotechnology, Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia
    • Corresponding Author InformationReprint requests: Signe Altmäe, M.Sc., Department of Obstetrics and Gynecology K57, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Stockholm, Sweden (FAX: +46858587575).
  • ,
  • Anneli Stavreus-Evers, Ph.D.

      Affiliations

    • Department of Women's and Children's Health, Uppsala University, Akademiska Sjukhuset, Uppsala
  • ,
  • Jonatan R. Ruiz, Ph.D.

      Affiliations

    • Department of Biosciences and Nutrition, Unit for Preventive Nutrition, Karolinska Institutet, Stockholm, Sweden
  • ,
  • Margit Laanpere, M.Sc.

      Affiliations

    • Department of Biotechnology, Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia
  • ,
  • Tiina Syvänen, M.Sc.

      Affiliations

    • Department of Women's and Children's Health, Uppsala University, Akademiska Sjukhuset, Uppsala
  • ,
  • Agneta Yngve, Ph.D.

      Affiliations

    • Department of Biosciences and Nutrition, Unit for Public Health Nutrition, Karolinska Institutet, Stockholm, Sweden
  • ,
  • Andres Salumets, Ph.D.

      Affiliations

    • Department of Biotechnology, Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia
    • Department of Obstetrics and Gynecology, University of Tartu, Tartu, Estonia
  • ,
  • Torbjörn K. Nilsson, M.D., Ph.D.

      Affiliations

    • Department of Clinical Chemistry, Örebro University Hospital, Örebro, Sweden

Received 15 December 2008 ,Revised 29 January 2009 ,Accepted 9 February 2009.

References 

  1. Tamura T, Picciano MF. Folate and human reproduction. Am J Clin Nutr. 2006;83:993–1016
  2. Jacques PF, Bostom AG, Wilson PW, Rich S, Rosenberg IH, Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr. 2001;73:613–621
  3. Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab. 2000;71:121–138
  4. Gmyrek GB, Sozanski R, Jerzak M, Chrobak A, Wickiewicz D, Skupnik A, et al. Evaluation of monocyte chemotactic protein-1 levels in peripheral blood of infertile women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2005;122:199–205
  5. Thaler CD, Epel D. Nitric oxide in oocyte maturation, ovulation, fertilization, cleavage and implantation: a little dab'll do ya. Curr Pharm Des. 2003;9:399–409
  6. Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2005;3:28
  7. Hussein MR. Apoptosis in the ovary: molecular mechanisms. Hum Reprod Update. 2005;11:162–177
  8. Forges T, Monnier-Barbarino P, Alberto JM, Gueant-Rodriguez RM, Daval JL, Gueant JL. Impact of folate and homocysteine metabolism on human reproductive health. Hum Reprod Update. 2007;13:225–238
  9. Mooij PN, Wouters MG, Thomas CM, Doesburg WH, Eskes TK. Disturbed reproductive performance in extreme folic acid deficient golden hamsters. Eur J Obstet Gynecol Reprod Biol. 1992;43:71–75
  10. Boxmeer JC, Brouns RM, Lindemans J, Steegers EA, Martini E, Macklon NS, et al. Preconception folic acid treatment affects the microenvironment of the maturing oocyte in humans. Fertil Steril. 2008;89:1766–1770
  11. Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC. Use of multivitamins, intake of B vitamins, and risk of ovulatory infertility. Fertil Steril. 2008;89:668–676
  12. Zetterberg H. Methylenetetrahydrofolate reductase and transcobalamin genetic polymorphisms in human spontaneous abortion: biological and clinical implications. Reprod Biol Endocrinol. 2004;2:7
  13. Narayanan S, McConnell J, Little J, Sharp L, Piyathilake CJ, Powers H, et al. Associations between two common variants C677T and A1298C in the methylenetetrahydrofolate reductase gene and measures of folate metabolism and DNA stability (strand breaks, misincorporated uracil, and DNA methylation status) in human lymphocytes in vivo. Cancer Epidemiol Biomarkers Prev. 2004;13:1436–1443
  14. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111–113
  15. Yamada K, Strahler JR, Andrews PC, Matthews RG. Regulation of human methylenetetrahydrofolate reductase by phosphorylation. Proc Natl Acad Sci U S A. 2005;102:10454–10459
  16. Harmon DL, Woodside JV, Yarnell JW, McMaster D, Young IS, McCrum EE, et al. The common “thermolabile” variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. QJM. 1996;89:571–577
  17. Altmae S, Haller K, Peters M, Hovatta O, Stavreus-Evers A, Karro H, et al. Allelic estrogen receptor 1 (ESR1) gene variants predict the outcome of ovarian stimulation in in vitro fertilization. Mol Hum Reprod. 2007;13:521–526
  18. WHO . Laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 4th ed.. Cambridge: Cambridge University Press; 1999;
  19. Böttiger AK, Hagnelius NO, Nilsson TK. Mutations in exons 2 and 3 of the FOLR1 gene in demented and non-demented elderly subjects. Int J Mol Med. 2007;20:653–662
  20. Böttiger AK, Hurtig-Wennlof A, Sjostrom M, Yngve A, Nilsson TK. Association of total plasma homocysteine with methylenetetrahydrofolate reductase genotypes 677C>T, 1298A>C, and 1793G>A and the corresponding haplotypes in Swedish children and adolescents. Int J Mol Med. 2007;19:659–665
  21. Böttiger AK, Nilsson TK. Pyrosequencing assay for genotyping of the Transcobalamin II 776C>G polymorphism. Scand J Clin Lab Invest. 2007;67:247–251
  22. Nilsson TK, Lof-Ohlin ZM, Bottiger AK. Genotyping of the reduced folate carrier-1 c.80G>A polymorphism by pyrosequencing technology: importance of PCR and pre-PCR optimization. Scand J Clin Lab Invest. 2008;68:166–170
  23. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–265
  24. Szymanski W, Kazdepka-Zieminska A. Effect of homocysteine concentration in follicular fluid on a degree of oocyte maturity. Ginekol Pol. 2003;74:1392–1396
  25. Ebisch IM, Peters WH, Thomas CM, Wetzels AM, Peer PG, Steegers-Theunissen RP. Homocysteine, glutathione and related thiols affect fertility parameters in the (sub)fertile couple. Hum Reprod. 2006;21:1725–1733
  26. Pacchiarotti A, Mohamed MA, Micara G, Linari A, Tranquilli D, Espinola SB, et al. The possible role of hyperhomocysteinemia on IVF outcome. J Assist Reprod Genet. 2007;24:459–462
  27. Fohr IP, Prinz-Langenohl R, Bronstrup A, Bohlmann AM, Nau H, Berthold HK, et al. 5,10-Methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women. Am J Clin Nutr. 2002;75:275–282
  28. Wang J, Huff AM, Spence JD, Hegele RA. Single nucleotide polymorphism in CTH associated with variation in plasma homocysteine concentration. Clin Genet. 2004;65:483–486
  29. Jongbloet PH, Verbeek AL, den Heijer M, Roeleveld N. Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms resulting in suboptimal oocyte maturation: a discussion of folate status, neural tube defects, schizophrenia, and vasculopathy. J Exp Clin Assist Reprod. 2008;5:5
  30. Thaler CJ, Budiman H, Ruebsamen H, Nagel D, Lohse P. Effects of the common 677C>T mutation of the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene on ovarian responsiveness to recombinant follicle-stimulating hormone. Am J Reprod Immunol. 2006;55:251–258
  31. Haggarty P, McCallum H, McBain H, Andrews K, Duthie S, McNeill G, et al. Effect of B vitamins and genetics on success of in-vitro fertilisation: prospective cohort study. Lancet. 2006;367:1513–1519
  32. Bae J, Shin SJ, Cha SH, Choi DH, Lee S, Kim NK. Prevalent genotypes of methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) in spontaneously aborted embryos. Fertil Steril. 2007;87:351–355
  33. Reyes-Engel A, Munoz E, Gaitan MJ, Fabre E, Gallo M, Dieguez JL, et al. Implications on human fertility of the 677C→T and 1298A→C polymorphisms of the MTHFR gene: consequences of a possible genetic selection. Mol Hum Reprod. 2002;8:952–957
  34. Rady PL, Szucs S, Grady J, Hudnall SD, Kellner LH, Nitowsky H, et al. Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A. Am J Med Genet. 2002;107:162–168
  35. Chen J, Ma J, Stampfer MJ, Palomeque C, Selhub J, Hunter DJ. Linkage disequilibrium between the 677C>T and 1298A>C polymorphisms in human methylenetetrahydrofolate reductase gene and their contributions to risk of colorectal cancer. Pharmacogenetics. 2002;12:339–342
  36. Shi M, Caprau D, Romitti P, Christensen K, Murray JC. Genotype frequencies and linkage disequilibrium in the CEPH human diversity panel for variants in folate pathway genes MTHFR, MTHFD, MTRR, RFC1, and GCP2. Birth Defects Res A Clin Mol Teratol. 2003;67:545–549
  37. Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci. 2001;22:195–201
  38. Coulam CB, Jeyendran RS, Fishel LA, Roussev R. Multiple thrombophilic gene mutations are risk factors for implantation failure. Reprod Biomed Online. 2006;12:322–327
  39. Keijzer MB, den Heijer M, Blom HJ, Bos GM, Willems HP, Gerrits WB, et al. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolatereductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis. Thromb Haemost. 2002;88:723–728
  40. Azem F, Many A, Ben Ami I, Yovel I, Amit A, Lessing JB, et al. Increased rates of thrombophilia in women with repeated IVF failures. Hum Reprod. 2004;19:368–370
  41. Rawlings ND, Barrett AJ. Evolutionary families of peptidases. Biochem J. 1993;290:205–218
  42. Matherly LH, Hou Z, Deng Y. Human reduced folate carrier: translation of basic biology to cancer etiology and therapy. Cancer Metastasis Rev. 2007;26:111–128
  43. Chango A, Emery-Fillon N, de Courcy GP, Lambert D, Pfister M, Rosenblatt DS, et al. A polymorphism (80G→A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol Genet Metab. 2000;70:310–315
  44. Whetstine JR, Gifford AJ, Witt T, Liu XY, Flatley RM, Norris M, et al. Single nucleotide polymorphisms in the human reduced folate carrier: characterization of a high-frequency G/A variant at position 80 and transport properties of the His(27) and Arg(27) carriers. Clin Cancer Res. 2001;7:3416–3422
  45. Nelen WL, Bulten J, Steegers EA, Blom HJ, Hanselaar AG, Eskes TK. Maternal homocysteine and chorionic vascularization in recurrent early pregnancy loss. Hum Reprod. 2000;15:954–960
  46. Yates Z, Lucock M. G80A reduced folate carrier SNP modulates cellular uptake of folate and affords protection against thrombosis via a non homocysteine related mechanism. Life Sci. 2005;77:2735–2742
  47. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet. 2003;361:901–908
  48. Gleicher N, Barad D. Unexplained infertility: does it really exist?. Hum Reprod. 2006;21:1951–1955
  49. Olive DL, Schwartz LB. Endometriosis. N Engl J Med. 1993;328:1759–1769

 S.A. has nothing to disclose. A.S.-E. has nothing to disclose. J.R.R. has nothing to disclose. M.L. has nothing to disclose. T.S. has nothing to disclose. A.Y. has nothing to disclose. A.S. has nothing to disclose. T.K.N. has nothing to disclose.

 Supported by the European Union via the European Regional Development Fund and the Centre of Excellence in Genomics, Estonian Biocentre and Tartu University; the Estonian Ministry of Education and Science (core grants nos. 0182641s04 and PBGMR07903); the Estonian Science Foundation (grant no. 6498); the Spanish Ministry of Education (EX-2007-1124); The Swedish Research Council (2005-7293); the Swedish Society of Medicine; the Magn. Bergvalls Foundation; the Goljes Foundation; the Åke Wibergs Foundation; Nyckelfonden, Örebro; Karolinska Institutet, and the County Council of Stockholm and Örebro.

PII: S0015-0282(09)00372-0

doi: 10.1016/j.fertnstert.2009.02.025

Fertility and Sterility
Volume 94, Issue 1 , Pages 130-137 , June 2010